345296-69-7

Basic information

• Product Name: 3-(3,5-Dichlorophenyl)-3-[5-oxo-1-[3-(1,4,5,6-tetrahydropyrimidin-2-ylamino)phenyl]pyrrolidin-3-ylcarboxamido]propionic acid
• CAS NO: 345296-69-7
• Molecular Formula: C₂₄H₂₅Cl₂N₅O₄
• Molecular Weight: 518.40395
• Mol File: 345296-69-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-(3,5-Dichlorophenyl)-3-[5-oxo-1-[3-(1,4,5,6-tetrahydropyrimidin-2-ylamino)phenyl]pyrrolidin-3-ylcarboxamido]propionic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(3,5-Dichlorophenyl)-3-[5-oxo-1-[3-(1,4,5,6-tetrahydropyrimidin-2-ylamino)phenyl]pyrrolidin-3-ylcarboxamido]propionic acid(345296-69-7)
• EPA Substance Registry System: 3-(3,5-Dichlorophenyl)-3-[5-oxo-1-[3-(1,4,5,6-tetrahydropyrimidin-2-ylamino)phenyl]pyrrolidin-3-ylcarboxamido]propionic acid(345296-69-7)

Safety Data

• Hazardous Substances Data: 345296-69-7(Hazardous Substances Data)

Relevant articles and documents

Integrin inhibitors and their methods of use

The invention comprises novel compounds that are effective in the prophylaxis and treatment of diseases, such as integrin receptors mediated diseases, in particular, diseases or conditions mediated by integrin receptors, such as a αvβ3, αvβ6, α5β1 and the like. The invention encompasses novel compounds, pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of such diseases and disorders. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.